SIMILAR PATTERNS OF AMINO ACIDS FOR 5IEN_B_VDYB201_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ir6 EXONUCLEASE RECJ

(Thermus
thermophilus)
PF01368
(DHH)
PF02272
(DHHA1)
5 PRO A 185
LEU A  55
ILE A  91
LEU A  92
LEU A  50
None
1.13A 5ienB-1ir6A:
0.0
5ienB-1ir6A:
14.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mv5 MULTIDRUG RESISTANCE
ABC TRANSPORTER
ATP-BINDING AND
PERMEASE PROTEIN


(Lactococcus
lactis)
PF00005
(ABC_tran)
5 ILE A 372
MET A 503
VAL A 348
ILE A 551
PRO A 395
None
0.95A 5ienB-1mv5A:
0.0
5ienB-1mv5A:
21.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nkq HYPOTHETICAL 28.8
KDA PROTEIN IN
PSD1-SKO1 INTERGENIC
REGION


(Saccharomyces
cerevisiae)
PF01557
(FAA_hydrolase)
5 ILE A 211
LEU A 213
VAL A 172
LEU A 233
LEU A   6
None
1.17A 5ienB-1nkqA:
0.0
5ienB-1nkqA:
18.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1obb ALPHA-GLUCOSIDASE

(Thermotoga
maritima)
PF02056
(Glyco_hydro_4)
PF11975
(Glyco_hydro_4C)
5 ILE A 345
VAL A  35
ILE A  48
LEU A  37
LEU A 322
None
0.77A 5ienB-1obbA:
0.0
5ienB-1obbA:
14.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1puj CONSERVED
HYPOTHETICAL PROTEIN
YLQF


(Bacillus
subtilis)
PF01926
(MMR_HSR1)
5 ILE A  85
LEU A  93
VAL A 163
ILE A 125
LEU A 169
None
1.15A 5ienB-1pujA:
undetectable
5ienB-1pujA:
20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1q5a EP-CADHERIN

(Mus musculus)
PF00028
(Cadherin)
5 ILE A  99
VAL A  62
ILE A   7
LEU A  21
PRO A  18
None
1.14A 5ienB-1q5aA:
undetectable
5ienB-1q5aA:
10.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1s2n EXTRACELLULAR
SUBTILISIN-LIKE
SERINE PROTEINASE


(Vibrio sp.
PA-44)
PF00082
(Peptidase_S8)
5 TYR A  22
VAL A  31
ILE A  78
PRO A 122
LEU A   8
None
1.00A 5ienB-1s2nA:
undetectable
5ienB-1s2nA:
16.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1sgw PUTATIVE ABC
TRANSPORTER


(Pyrococcus
furiosus)
PF00005
(ABC_tran)
5 ILE A  85
LEU A 123
VAL A 116
ILE A 107
LEU A 111
None
1.19A 5ienB-1sgwA:
0.0
5ienB-1sgwA:
18.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tez DEOXYRIBODIPYRIMIDIN
E PHOTOLYASE


(Synechococcus
elongatus)
PF00875
(DNA_photolyase)
PF03441
(FAD_binding_7)
5 ILE A 354
PRO A 408
ILE A 422
LEU A 426
PRO A 451
None
1.14A 5ienB-1tezA:
undetectable
5ienB-1tezA:
14.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u60 PROBABLE GLUTAMINASE
YBAS


(Escherichia
coli)
PF04960
(Glutaminase)
5 ILE A 142
LEU A 226
VAL A 269
LEU A 267
PRO A 257
None
1.18A 5ienB-1u60A:
undetectable
5ienB-1u60A:
20.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wzx COG3291: FOG: PKD
REPEAT


(Ruminiclostridium
thermocellum)
no annotation 5 ILE A 138
LEU A 143
VAL A 155
ILE A  13
LEU A  70
None
1.09A 5ienB-1wzxA:
undetectable
5ienB-1wzxA:
22.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1x4f MATRIN 3

(Mus musculus)
PF00076
(RRM_1)
5 PRO A  49
VAL A  94
ILE A  28
LEU A  30
PRO A  34
None
1.00A 5ienB-1x4fA:
undetectable
5ienB-1x4fA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xkw FE(III)-PYOCHELIN
RECEPTOR


(Pseudomonas
aeruginosa)
PF00593
(TonB_dep_Rec)
PF07715
(Plug)
5 VAL A 518
ILE A 545
LEU A 547
PRO A 551
LEU A 159
None
1.06A 5ienB-1xkwA:
1.2
5ienB-1xkwA:
10.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1y9i LOW TEMPERATURE
REQUIREMENT C
PROTEIN


(Listeria
monocytogenes)
PF04608
(PgpA)
5 LEU A  56
VAL A 147
ILE A  69
LEU A 143
LEU A  10
None
1.15A 5ienB-1y9iA:
undetectable
5ienB-1y9iA:
27.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ztd HYPOTHETICAL PROTEIN
PFU-631545-001


(Pyrococcus
furiosus)
PF11469
(Ribonucleas_3_2)
5 ILE A  86
PRO A 111
VAL A  35
ILE A  69
PRO A  36
None
1.09A 5ienB-1ztdA:
undetectable
5ienB-1ztdA:
23.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2abj BRANCHED-CHAIN-AMINO
-ACID
AMINOTRANSFERASE,
CYTOSOLIC


(Homo sapiens)
PF01063
(Aminotran_4)
5 LEU A 261
VAL A 323
ILE A 348
LEU A 318
LEU A 246
None
1.18A 5ienB-2abjA:
undetectable
5ienB-2abjA:
15.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2f5y REGULATOR OF
G-PROTEIN SIGNALLING
3 ISOFORM 1


(Homo sapiens)
PF00595
(PDZ)
5 ILE A  21
LEU A  54
VAL A  38
LEU A  76
PRO A  37
None
1.09A 5ienB-2f5yA:
undetectable
5ienB-2f5yA:
19.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gzq PHOSPHATIDYLETHANOLA
MINE-BINDING PROTEIN


(Plasmodium
vivax)
PF01161
(PBP)
5 MET A  31
LEU A  27
VAL A  19
ILE A 174
PRO A  78
None
1.18A 5ienB-2gzqA:
undetectable
5ienB-2gzqA:
22.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iuj LIPOXYGENASE L-5

(Glycine max)
PF00305
(Lipoxygenase)
PF01477
(PLAT)
5 ILE A 326
LEU A 329
ILE A 764
LEU A 768
LEU A 338
None
1.12A 5ienB-2iujA:
undetectable
5ienB-2iujA:
10.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iy8 PROTEIN PM0188

(Pasteurella
multocida)
PF11477
(PM0188)
5 ILE A 184
VAL A 195
ILE A 110
LEU A 138
LEU A 211
None
1.19A 5ienB-2iy8A:
undetectable
5ienB-2iy8A:
16.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2obn HYPOTHETICAL PROTEIN

(Trichormus
variabilis)
PF07755
(DUF1611)
PF17396
(DUF1611_N)
5 ILE A 129
LEU A  99
VAL A  65
ILE A  78
LEU A  12
None
1.13A 5ienB-2obnA:
undetectable
5ienB-2obnA:
19.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2okx RHAMNOSIDASE B

(Bacillus sp.
GL1)
PF05592
(Bac_rhamnosid)
PF08531
(Bac_rhamnosid_N)
PF17389
(Bac_rhamnosid6H)
PF17390
(Bac_rhamnosid_C)
5 ILE A 318
LEU A 260
ILE A 249
LEU A 300
PRO A 368
None
None
None
None
GOL  A3017 (-4.2A)
1.09A 5ienB-2okxA:
undetectable
5ienB-2okxA:
10.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p67 LAO/AO TRANSPORT
SYSTEM KINASE


(Escherichia
coli)
PF03308
(ArgK)
5 ILE A 246
LEU A  77
VAL A 149
ILE A 172
LEU A  57
None
0.82A 5ienB-2p67A:
undetectable
5ienB-2p67A:
17.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qn0 NEUROTOXIN

(Clostridium
botulinum)
PF01742
(Peptidase_M27)
5 TYR A  76
PRO A 168
ILE A  90
LEU A  93
LEU A  77
None
1.19A 5ienB-2qn0A:
undetectable
5ienB-2qn0A:
15.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r98 PUTATIVE
ACETYLGLUTAMATE
SYNTHASE


(Neisseria
gonorrhoeae)
PF00583
(Acetyltransf_1)
PF00696
(AA_kinase)
6 ILE A 167
LEU A 125
VAL A 102
ILE A  30
LEU A  35
LEU A  50
None
1.49A 5ienB-2r98A:
undetectable
5ienB-2r98A:
13.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wed PENICILLOPEPSIN

(Penicillium
janthinellum)
PF00026
(Asp)
5 ILE A 297
VAL A 184
LEU A 317
PRO A 315
LEU A 221
PP6  A 327 (-4.2A)
None
None
None
None
1.19A 5ienB-2wedA:
undetectable
5ienB-2wedA:
16.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a3i PENICILLIN-BINDING
PROTEIN 4


(Haemophilus
influenzae)
PF02113
(Peptidase_S13)
5 MET A 306
LEU A 389
VAL A 376
ILE A 343
LEU A 344
None
1.16A 5ienB-3a3iA:
undetectable
5ienB-3a3iA:
15.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3all 2-METHYL-3-HYDROXYPY
RIDINE-5-CARBOXYLIC
ACID OXYGENASE


(Mesorhizobium
japonicum)
PF01494
(FAD_binding_3)
5 LEU A 242
VAL A 184
ILE A 212
LEU A 224
PRO A 185
None
1.07A 5ienB-3allA:
undetectable
5ienB-3allA:
18.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3djn PROTEIN BTG2

(Mus musculus)
PF07742
(BTG)
5 ILE B  78
LEU B  92
VAL B  30
LEU B  35
LEU B 102
None
0.98A 5ienB-3djnB:
undetectable
5ienB-3djnB:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gvh MALATE DEHYDROGENASE

(Brucella
abortus)
PF00056
(Ldh_1_N)
PF02866
(Ldh_1_C)
5 ILE A 288
LEU A 290
VAL A 266
ILE A 285
LEU A 260
None
1.08A 5ienB-3gvhA:
undetectable
5ienB-3gvhA:
18.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hb0 EYES ABSENT HOMOLOG
2 (DROSOPHILA)


(Homo sapiens)
PF00702
(Hydrolase)
5 ILE A 520
VAL A 466
ILE A 280
LEU A 463
PRO A 468
None
1.17A 5ienB-3hb0A:
undetectable
5ienB-3hb0A:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hbj FLAVONOID
3-O-GLUCOSYLTRANSFER
ASE


(Medicago
truncatula)
PF00201
(UDPGT)
5 ILE A 231
PRO A 180
LEU A 153
VAL A 194
LEU A 190
None
1.00A 5ienB-3hbjA:
undetectable
5ienB-3hbjA:
15.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hje 704AA LONG
HYPOTHETICAL
GLYCOSYLTRANSFERASE


(Sulfurisphaera
tokodaii)
PF00128
(Alpha-amylase)
PF09196
(DUF1953)
5 TYR A 233
ILE A 221
VAL A  50
ILE A 211
LEU A  38
None
1.18A 5ienB-3hjeA:
undetectable
5ienB-3hjeA:
11.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3hx8 PUTATIVE KETOSTEROID
ISOMERASE


(Mesorhizobium
loti)
PF14534
(DUF4440)
5 TYR A  52
LEU A  75
LEU A 109
PRO A 112
LEU A 139
None
None
UNL  A 200 (-4.9A)
None
None
0.54A 5ienB-3hx8A:
22.6
5ienB-3hx8A:
89.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3hx8 PUTATIVE KETOSTEROID
ISOMERASE


(Mesorhizobium
loti)
PF14534
(DUF4440)
5 TYR A  52
PRO A  60
LEU A 109
PRO A 112
LEU A 139
None
None
UNL  A 200 (-4.9A)
None
None
0.88A 5ienB-3hx8A:
22.6
5ienB-3hx8A:
89.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ian CHITINASE

(Lactococcus
lactis)
PF00704
(Glyco_hydro_18)
5 ILE A 145
LEU A 179
ILE A 131
LEU A 161
PRO A 199
None
1.12A 5ienB-3ianA:
undetectable
5ienB-3ianA:
21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jd5 28S RIBOSOMAL
PROTEIN S27,
MITOCHONDRIAL


(Bos taurus)
PF00333
(Ribosomal_S5)
PF03719
(Ribosomal_S5_C)
5 ILE e 137
PRO e 139
LEU e 129
LEU e 117
LEU e  92
None
1.00A 5ienB-3jd5e:
undetectable
5ienB-3jd5e:
14.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jxo TRKA-N DOMAIN
PROTEIN


(Thermotoga sp.
RQ2)
PF02080
(TrkA_C)
5 ILE A 178
PRO A 187
LEU A 199
PRO A 170
LEU A 194
None
1.16A 5ienB-3jxoA:
undetectable
5ienB-3jxoA:
23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3k2g RESINIFERATOXIN-BIND
ING,
PHOSPHOTRIESTERASE-R
ELATED PROTEIN


(Rhodobacter
sphaeroides)
PF02126
(PTE)
5 ILE A 262
ILE A 297
LEU A 288
PRO A 244
LEU A 325
None
1.16A 5ienB-3k2gA:
undetectable
5ienB-3k2gA:
19.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kcq PHOSPHORIBOSYLGLYCIN
AMIDE
FORMYLTRANSFERASE


(Anaplasma
phagocytophilum)
PF00551
(Formyl_trans_N)
5 ILE A  11
VAL A  79
ILE A  70
LEU A  74
LEU A  47
None
1.18A 5ienB-3kcqA:
undetectable
5ienB-3kcqA:
20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lye OXALOACETATE ACETYL
HYDROLASE


(Cryphonectria
parasitica)
PF13714
(PEP_mutase)
5 PRO A 151
VAL A 255
ILE A 306
LEU A 280
PRO A 278
None
1.16A 5ienB-3lyeA:
undetectable
5ienB-3lyeA:
18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3prx COBRA VENOM FACTOR

(Naja kaouthia)
PF00207
(A2M)
PF01759
(NTR)
PF01821
(ANATO)
PF01835
(A2M_N)
PF07677
(A2M_recep)
PF07678
(A2M_comp)
PF07703
(A2M_N_2)
PF10569
(Thiol-ester_cl)
5 LEU B1345
VAL B1430
ILE B1425
LEU B1427
LEU B1365
None
1.19A 5ienB-3prxB:
undetectable
5ienB-3prxB:
6.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pzy MOG

(Mycobacterium
avium)
PF00994
(MoCF_biosynth)
6 ILE A  28
VAL A  51
ILE A  66
LEU A  55
PRO A  50
LEU A 142
None
1.39A 5ienB-3pzyA:
undetectable
5ienB-3pzyA:
23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q0x CENTRIOLE PROTEIN

(Chlamydomonas
reinhardtii)
PF16531
(SAS-6_N)
5 LEU A 128
VAL A  29
ILE A 106
LEU A 110
PRO A  28
None
1.09A 5ienB-3q0xA:
2.7
5ienB-3q0xA:
24.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qeh FAB FRAGMENT OF
HUMAN ANTI-HIV-1 ENV
ANTIBODY N12-I15,
HEAVY CHAIN


(Homo sapiens)
PF07654
(C1-set)
PF07686
(V-set)
5 TYR A 176
LEU A 108
VAL A  18
LEU A  82
LEU A 170
None
1.17A 5ienB-3qehA:
undetectable
5ienB-3qehA:
21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3s95 LIM DOMAIN KINASE 1

(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 PRO A 433
VAL A 468
ILE A 542
LEU A 421
LEU A 607
None
1.13A 5ienB-3s95A:
undetectable
5ienB-3s95A:
20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tej ENTEROBACTIN
SYNTHASE COMPONENT F


(Escherichia
coli)
PF00550
(PP-binding)
PF00975
(Thioesterase)
5 ILE A1094
LEU A1068
ILE A1275
LEU A1164
LEU A1058
None
1.15A 5ienB-3tejA:
undetectable
5ienB-3tejA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3to3 PETROBACTIN
BIOSYNTHESIS PROTEIN
ASBB


(Bacillus
anthracis)
PF04183
(IucA_IucC)
PF06276
(FhuF)
5 PRO A 162
LEU A  32
VAL A 110
ILE A 119
LEU A 115
None
1.19A 5ienB-3to3A:
2.5
5ienB-3to3A:
11.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3uss PUTATIVE
UNCHARACTERIZED
PROTEIN


(Pseudomonas
aeruginosa)
PF05995
(CDO_I)
5 ILE A 192
PRO A 190
LEU A   7
ILE A 156
LEU A 100
None
NA  A 218 ( 4.2A)
None
None
None
1.18A 5ienB-3ussA:
undetectable
5ienB-3ussA:
22.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vu1 PUTATIVE
UNCHARACTERIZED
PROTEIN PH0242


(Pyrococcus
horikoshii)
no annotation 5 PRO A 953
LEU A 830
VAL A 861
ILE A 909
LEU A 911
None
1.07A 5ienB-3vu1A:
undetectable
5ienB-3vu1A:
15.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wel ALPHA-GLUCOSIDASE

(Beta vulgaris)
PF01055
(Glyco_hydro_31)
PF13802
(Gal_mutarotas_2)
PF16863
(NtCtMGAM_N)
6 TYR A 283
ILE A 281
VAL A 303
ILE A 294
PRO A 300
LEU A 196
None
1.46A 5ienB-3welA:
1.3
5ienB-3welA:
8.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zu4 PUTATIVE REDUCTASE
YPO4104/Y4119/YP_401
1


(Yersinia pestis)
PF07055
(Eno-Rase_FAD_bd)
PF12241
(Enoyl_reductase)
PF12242
(Eno-Rase_NADH_b)
5 ILE A 254
LEU A 258
VAL A 132
ILE A  47
LEU A  45
None
1.00A 5ienB-3zu4A:
undetectable
5ienB-3zu4A:
15.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a9a RIBOSOME-INTERACTING
GTPASE 1


(Saccharomyces
cerevisiae)
PF01926
(MMR_HSR1)
PF02824
(TGS)
PF16897
(MMR_HSR1_Xtn)
5 ILE A 272
LEU A  81
VAL A  68
LEU A 145
LEU A 249
None
1.07A 5ienB-4a9aA:
undetectable
5ienB-4a9aA:
16.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4axn CHITINASE C1

(Serratia
marcescens)
PF00704
(Glyco_hydro_18)
5 ILE A 124
LEU A 158
ILE A 110
LEU A 140
PRO A 178
None
1.13A 5ienB-4axnA:
undetectable
5ienB-4axnA:
14.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4b3i FATTY ACID
BETA-OXIDATION
COMPLEX ALPHA-CHAIN
FADB
FATTY ACID
BETA-OXIDATION
COMPLEX BETA-CHAIN
FADA


(Mycobacterium
tuberculosis)
PF00108
(Thiolase_N)
PF00378
(ECH_1)
PF00725
(3HCDH)
PF02737
(3HCDH_N)
PF02803
(Thiolase_C)
5 TYR A 286
ILE A 282
VAL C 194
LEU C  31
PRO C  14
None
1.02A 5ienB-4b3iA:
undetectable
5ienB-4b3iA:
11.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dzt AQUALYSIN-1

(Thermus
aquaticus)
PF00082
(Peptidase_S8)
5 TYR A  24
VAL A  33
ILE A  78
PRO A 122
LEU A  10
None
1.01A 5ienB-4dztA:
undetectable
5ienB-4dztA:
17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4e4u MANDALATE
RACEMASE/MUCONATE
LACTONIZING ENZYME


(unidentified)
PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C)
5 ILE A   3
PRO A  67
LEU A 366
PRO A 364
LEU A   6
None
1.17A 5ienB-4e4uA:
undetectable
5ienB-4e4uA:
14.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gip FUSION GLYCOPROTEIN
F1


(Mammalian
rubulavirus 5)
PF00523
(Fusion_gly)
5 ILE D 206
LEU D 203
ILE D 259
LEU D 262
LEU D 224
None
1.17A 5ienB-4gipD:
undetectable
5ienB-4gipD:
18.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gw9 BACTERIOPHYTOCHROME

(Rhodopseudomonas
palustris)
PF00360
(PHY)
PF00989
(PAS)
PF01590
(GAF)
PF08446
(PAS_2)
5 ILE A  47
LEU A  64
ILE A 118
LEU A 240
LEU A  58
None
1.16A 5ienB-4gw9A:
undetectable
5ienB-4gw9A:
11.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nnb OBCA, OXALATE
BIOSYNTHETIC
COMPONENT A


(Burkholderia
glumae)
PF05853
(BKACE)
5 ILE A 446
LEU A 456
ILE A 405
LEU A 409
LEU A 463
None
1.20A 5ienB-4nnbA:
undetectable
5ienB-4nnbA:
13.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qaf LIPOCALIN-1

(Homo sapiens)
PF00061
(Lipocalin)
5 ILE A  80
LEU A  19
VAL A  53
LEU A 115
PRO A  38
None
1.16A 5ienB-4qafA:
undetectable
5ienB-4qafA:
20.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qi7 CELLOBIOSE
DEHYDROGENASE


(Neurospora
crassa)
PF00732
(GMC_oxred_N)
PF00734
(CBM_1)
PF05199
(GMC_oxred_C)
PF16010
(CDH-cyt)
5 PRO A 579
LEU A 382
VAL A 668
ILE A 537
LEU A 671
None
None
NAG  A 908 ( 4.8A)
None
None
1.13A 5ienB-4qi7A:
undetectable
5ienB-4qi7A:
10.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ttw CENTRIOLE PROTEIN

(Chlamydomonas
reinhardtii)
PF16531
(SAS-6_N)
5 LEU A 128
VAL A  29
ILE A 106
LEU A 110
PRO A  28
None
1.19A 5ienB-4ttwA:
undetectable
5ienB-4ttwA:
26.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4twg MOLYBDOPTERIN
BIOSYNTHESIS MOG
PROTEIN


(Mycobacterium
ulcerans)
PF00994
(MoCF_biosynth)
6 ILE A  29
VAL A  52
ILE A  67
LEU A  56
PRO A  51
LEU A 143
None
1.40A 5ienB-4twgA:
undetectable
5ienB-4twgA:
22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4w5z CHITINASE 60

(Moritella
marina)
PF00704
(Glyco_hydro_18)
5 ILE A 136
LEU A 170
ILE A 122
LEU A 152
PRO A 190
None
1.12A 5ienB-4w5zA:
undetectable
5ienB-4w5zA:
17.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wj7 MALCAVERNIN

(Homo sapiens)
no annotation 5 ILE A  76
LEU A  80
VAL A 145
ILE A 197
LEU A 152
None
1.16A 5ienB-4wj7A:
undetectable
5ienB-4wj7A:
20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wnr LEUCINE-RICH-REPEAT
PROTEIN


(Methanosarcina
barkeri)
PF08477
(Roc)
PF16095
(COR)
5 ILE A 458
LEU A 337
VAL A 324
LEU A 396
LEU A 429
None
1.05A 5ienB-4wnrA:
undetectable
5ienB-4wnrA:
16.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wnz CRISPR SYSTEM CMR
SUBUNIT CMR4


(Pyrococcus
furiosus)
PF03787
(RAMPs)
5 ILE A  82
LEU A 258
VAL A 281
LEU A   8
LEU A 241
None
1.12A 5ienB-4wnzA:
undetectable
5ienB-4wnzA:
21.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yeb FIBRONECTIN LEUCINE
RICH TRANSMEMBRANE
PROTEIN 3


(Mus musculus)
PF13855
(LRR_8)
5 ILE B 177
PRO B 174
LEU B 159
VAL B 140
LEU B 204
None
1.11A 5ienB-4yebB:
undetectable
5ienB-4yebB:
13.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ym3 GALECTIN-4

(Homo sapiens)
PF00337
(Gal-bind_lectin)
5 MET A 241
VAL A 192
ILE A 210
LEU A 318
LEU A 235
None
1.04A 5ienB-4ym3A:
1.6
5ienB-4ym3A:
18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5b4x REELIN

(Mus musculus)
PF07974
(EGF_2)
5 ILE A2656
LEU A2563
VAL A2566
ILE A2661
LEU A2568
None
1.17A 5ienB-5b4xA:
undetectable
5ienB-5b4xA:
10.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5bz3 NA(+)/H(+)
ANTIPORTER


(Thermus
thermophilus)
PF00999
(Na_H_Exchanger)
5 ILE A 261
PRO A 260
LEU A 220
VAL A 212
LEU A 207
None
1.17A 5ienB-5bz3A:
undetectable
5ienB-5bz3A:
14.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5c0u ALKYLMERCURY LYASE

(Escherichia
coli)
PF03243
(MerB)
PF12324
(HTH_15)
5 ILE A  45
LEU A  46
VAL A  56
ILE A  71
LEU A  57
None
1.15A 5ienB-5c0uA:
undetectable
5ienB-5c0uA:
18.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5chn ANTIBODY 5M16 FAB
HEAVY CHAIN


(Homo sapiens)
no annotation 5 TYR H 185
LEU H 117
VAL H  18
LEU H  86
LEU H 179
None
1.18A 5ienB-5chnH:
undetectable
5ienB-5chnH:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e6s INTEGRIN ALPHA-L

(Homo sapiens)
PF00092
(VWA)
PF01839
(FG-GAP)
PF08441
(Integrin_alpha2)
5 VAL A  58
ILE A  83
LEU A 111
PRO A  57
LEU A 359
None
1.12A 5ienB-5e6sA:
undetectable
5ienB-5e6sA:
9.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ej1 PUTATIVE CELLULOSE
SYNTHASE


(Rhodobacter
sphaeroides)
PF03170
(BcsB)
5 ILE B 197
PRO B 233
VAL B 268
ILE B 258
LEU B 282
None
1.13A 5ienB-5ej1B:
undetectable
5ienB-5ej1B:
12.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5end 3-OXOACYL-[ACYL-CARR
IER-PROTEIN]
REDUCTASE FABG


(Vibrio cholerae)
PF13561
(adh_short_C2)
5 ILE A 118
MET A 169
VAL A  84
ILE A  70
LEU A  74
None
1.11A 5ienB-5endA:
undetectable
5ienB-5endA:
21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5eqv BIFUNCTIONAL
2',3'-CYCLIC
NUCLEOTIDE
2'-PHOSPHODIESTERASE
/3'-NUCLEOTIDASE
PERIPLASMIC
PRECURSOR PROTEIN


(Yersinia pestis)
PF00149
(Metallophos)
5 TYR A 117
ILE A  67
LEU A  35
VAL A 294
PRO A 271
None
1.16A 5ienB-5eqvA:
0.4
5ienB-5eqvA:
18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5g5f TAU CLASS
GLUTATHIONE
S-TRANSFERASE


(Mangifera
indica)
PF00043
(GST_C)
PF02798
(GST_N)
5 ILE A  71
LEU A   8
VAL A 206
ILE A 161
PRO A 208
None
1.16A 5ienB-5g5fA:
undetectable
5ienB-5g5fA:
21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gkq ALYGC MUTANT - R241A

(Paraglaciecola
chathamensis)
PF14592
(Chondroitinas_B)
5 LEU A 532
VAL A 474
ILE A 486
LEU A 452
LEU A 546
None
1.13A 5ienB-5gkqA:
undetectable
5ienB-5gkqA:
10.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ieo CDL2.3A

(synthetic
construct)
PF14534
(DUF4440)
7 ILE A  37
PRO A  39
MET A  42
LEU A  54
VAL A  63
LEU A  88
LEU A 118
VDY  A 206 ( 3.9A)
VDY  A 206 ( 3.5A)
VDY  A 206 ( 3.5A)
VDY  A 206 ( 3.9A)
None
VDY  A 206 (-4.6A)
VDY  A 206 ( 4.4A)
0.68A 5ienB-5ieoA:
22.7
5ienB-5ieoA:
91.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ieo CDL2.3A

(synthetic
construct)
PF14534
(DUF4440)
7 TYR A  31
ILE A  37
PRO A  39
MET A  42
LEU A  54
VAL A  63
LEU A 118
None
VDY  A 206 ( 3.9A)
VDY  A 206 ( 3.5A)
VDY  A 206 ( 3.5A)
VDY  A 206 ( 3.9A)
None
VDY  A 206 ( 4.4A)
0.25A 5ienB-5ieoA:
22.7
5ienB-5ieoA:
91.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ieo CDL2.3A

(synthetic
construct)
PF14534
(DUF4440)
5 TYR A  31
LEU A  54
VAL A  63
PRO A  91
LEU A 118
None
VDY  A 206 ( 3.9A)
None
None
VDY  A 206 ( 4.4A)
0.90A 5ienB-5ieoA:
22.7
5ienB-5ieoA:
91.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j5v IMMUNITY PROTEIN
CDII


(Escherichia
coli)
no annotation 5 ILE C  53
LEU C  56
VAL C  63
LEU C  64
LEU C  90
None
1.18A 5ienB-5j5vC:
undetectable
5ienB-5j5vC:
21.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5k1u NAD(P)H:FLAVIN
OXIDOREDUCTASE SYE4


(Shewanella
oneidensis)
PF00724
(Oxidored_FMN)
5 PRO A 326
LEU A 343
VAL A  10
ILE A  29
LEU A  13
None
1.15A 5ienB-5k1uA:
undetectable
5ienB-5k1uA:
18.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5m2n ELONGATOR COMPLEX
PROTEIN 2


(Saccharomyces
cerevisiae)
PF00400
(WD40)
5 ILE A 729
PRO A 751
ILE A 782
LEU A 400
LEU A 731
None
1.12A 5ienB-5m2nA:
2.9
5ienB-5m2nA:
10.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mg3 PROTEIN TRANSLOCASE
SUBUNIT SECD


(Escherichia
coli)
PF02355
(SecD_SecF)
PF07549
(Sec_GG)
PF13721
(SecD-TM1)
5 ILE D 435
LEU D 234
VAL D 370
ILE D 272
LEU D 386
None
1.18A 5ienB-5mg3D:
undetectable
5ienB-5mg3D:
12.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nnl INACTIVE
DIHYDROOROTASE-LIKE
DOMAIN


(Chaetomium
thermophilum)
no annotation 5 TYR A1557
ILE A1736
PRO A1740
VAL A1810
LEU A1824
None
1.17A 5ienB-5nnlA:
undetectable
5ienB-5nnlA:
15.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nug CYTOPLASMIC DYNEIN 1
HEAVY CHAIN 1


(Homo sapiens)
PF03028
(Dynein_heavy)
PF07728
(AAA_5)
PF08393
(DHC_N2)
PF12774
(AAA_6)
PF12775
(AAA_7)
PF12777
(MT)
PF12780
(AAA_8)
PF12781
(AAA_9)
5 ILE A2990
MET A2994
LEU A3062
VAL A3017
LEU A3020
None
1.07A 5ienB-5nugA:
undetectable
5ienB-5nugA:
2.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5twa BAK-2 PROTEIN
BCL-X HOMOLOGOUS
PROTEIN, BHP2


(Geodia
cydonium;
Lubomirskia
baicalensis)
PF00452
(Bcl-2)
no annotation
5 TYR A 190
MET A  29
ILE A  94
LEU D  75
LEU A 194
None
None
None
EDO  D 102 ( 4.5A)
None
1.11A 5ienB-5twaA:
undetectable
5ienB-5twaA:
21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u8s CELL DIVISION
CONTROL PROTEIN 45


(Saccharomyces
cerevisiae)
PF02724
(CDC45)
5 ILE E 368
LEU E 334
VAL E 344
LEU E 348
LEU E 370
None
1.13A 5ienB-5u8sE:
undetectable
5ienB-5u8sE:
13.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u99 ATP
PHOSPHORIBOSYLTRANSF
ERASE


(Mycobacterium
tuberculosis)
PF01634
(HisG)
PF08029
(HisG_C)
5 ILE A 269
VAL A 254
ILE A 274
LEU A 215
PRO A 255
None
1.19A 5ienB-5u99A:
undetectable
5ienB-5u99A:
20.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xxi CYTOCHROME P450 2C9

(Homo sapiens)
no annotation 5 PRO A 382
LEU A  29
VAL A  64
ILE A 387
LEU A  77
None
1.17A 5ienB-5xxiA:
undetectable
5ienB-5xxiA:
14.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5yu1 LYSINE
CYCLODEAMINASE


(Streptomyces
pristinaespiralis)
no annotation 5 PRO A 217
VAL A 224
ILE A 230
LEU A 228
LEU A 270
None
1.18A 5ienB-5yu1A:
1.5
5ienB-5yu1A:
19.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5yv5 ATPASE RIL

(Pyrococcus
furiosus)
no annotation 5 ILE A 474
LEU A 508
VAL A 356
ILE A 395
LEU A 345
None
0.99A 5ienB-5yv5A:
undetectable
5ienB-5yv5A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5zvs VP2

(Aquareovirus C)
no annotation 5 TYR 21116
ILE 21191
PRO 21192
VAL 21248
LEU 21180
None
1.15A 5ienB-5zvs2:
undetectable
5ienB-5zvs2:
17.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6d85 PHOSPHATIDYLINOSITOL
3-KINASE REGULATORY
SUBUNIT ALPHA


(Bos taurus)
no annotation 5 ILE B 294
LEU B 244
VAL B 197
PRO B 199
LEU B 250
None
1.17A 5ienB-6d85B:
undetectable
5ienB-6d85B:
21.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ezm IMIDAZOLEGLYCEROL-PH
OSPHATE DEHYDRATASE


(Saccharomyces
cerevisiae)
no annotation 5 LEU U  69
VAL U 177
ILE U 173
LEU U 175
LEU U  23
None
1.18A 5ienB-6ezmU:
undetectable
5ienB-6ezmU:
18.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fpc PRO-PRO
ENDOPEPTIDASE


(Paenibacillus
alvei)
no annotation 5 LEU A  36
VAL A 143
ILE A 136
LEU A 140
LEU A  76
None
1.19A 5ienB-6fpcA:
undetectable
5ienB-6fpcA:
23.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6gdg TRXA,ADENOSINE
RECEPTOR A2A


(Escherichia
coli;
Homo sapiens)
no annotation 5 ILE A 127
LEU A 131
VAL A 188
ILE A 100
LEU A 192
None
1.02A 5ienB-6gdgA:
undetectable
5ienB-6gdgA:
20.74